Related Articles
Combretastatin A-4-phosphate effectively increases tumor retention of the therapeutic antibody, 131I-A5B7, even at doses that are sub-optimal for vascular shut-down
LINC00460 accelerates progression of ovarian cancer by activating transcriptional factor ZNF703
Radioimmunotherapy of orthotopically transplanted pancreatic cancer with 131I-labeled chimeric monoclonal antibody Nd2.
Treatment of 131I-labeled anti-CD147 monoclonal antibody in VX2 carcinoma-induced liver tumors
Naringin inhibits ovarian tumor growth by promoting apoptosis: An in vivo study